Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Gregory Weitsman, Paul R. Barber, Lan K. Nguyen, Katherine Lawler, Gargi Patel, Natalie Woodman, Muireann T. Kelleher, Sarah E. Pinder, Mark Rowley, Paul A. Ellis, Anand D. Purushotham, Anthonius C. Coolen, Boris N. Kholodenko, Borivoj Vojnovic, Cheryl Gillett, Tony Ng
Published Jul 7, 2016 · Vol. 7, No. 32 · pp. 51012-51026
Carlo Cenciarelli, Hany E. Marei, Armando Felsani, Patrizia Casalbore, Gigliola Sica, Maria Ausiliatrice Puglisi, Angus JM Cameron, Alessandro Olivi, Annunziato Mangiola
Published Jun 17, 2016 · Vol. 7, No. 33 · pp. 53047-53063
Xiaoran Li, Yali Zhong, Jie Lu, Karol Axcrona, Lars Eide, Randi G. Syljuåsen, Qian Peng, Junbai Wang, Hongquan Zhang, Mariusz Adam Goscinski, Gunnar Kvalheim, Jahn M. Nesland, Zhenhe Suo
Published May 26, 2016 · Vol. 7, No. 26 · pp. 40297-40313